ENPP2 and nervous system disorder: More recently, cannabinoids have been used as ATX inhibitors, the most potent of them being MEY-003, which has been found to inhibit in vitro (but it has potential to be orally bioavailable) both ATX β and ATX γ, making it a possible therapeutic agent to treat neurological disorders [205].